In this retrospective cohort study focusing on Moroccan patients with early-stage breast cancer, we did not observe any significant differences in tumor size, histologic grade, lymph node involvement, or OS between HER2-low and HER2-zero tumors in the general population. Here, ERBB2 is linked to breast carcinoma.